Zinc Gluconate
4468-02-4O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.[Zn+2]WHMDKBIGKVEYHS-IYEMJOQQSA-LZinc gluconate is a L-alpha-D-Hepp-(1->7)-L-alpha-D-Hepp-(1->3)-L-alpha-D-Hepp-(1->5)-alpha-Kdo.
4468-02-4DTXSID20894125CHEMBL3833377CHEBI:29708Cosmetic ingredients (Zinc Gluconate) -> CIR (Cosmetic Ingredient Review)
Skin conditioning; Deodorant
안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
This chemical does not meet GHS hazard criteria for 14.7% (39 of 266) of reports.
Danger
H318 (81.6%): Causes serious eye damage [Danger Serious eye damage/eye irritation]
P264+P265, P273, P280, P305+P354+P338, P317, P391, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 266 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Chemical: Zinc, bis(D-gluconato-.kappa.O1,.kappa.O2)-, (T-4)-
REACH registered substance: Bis(D-gluconato-O1,O2)zinc (EC: 224-736-9)
Zinc, bis(D-gluconato-.kappa.O1,.kappa.O2)-, (T-4)-: Does not have an individual approval but may be used under an appropriate group standard
Generally regarded as safe (GRAS) for use as dietary supplement and nutrient; [HSDB] At oral doses of 47 mg/kg, volunteers complained of distorted perceptions and nausea or vomiting; Intravenous LD50 (mouse) = 23.7 mg/kg; Oral LD50 (mouse) = 1290 mg/kg; [ChemIDplus] May cause irritation; [MSDSonline] See Zinc.
Zinc and Health. Current Bibliographies in Medicine 98-3. Public Services Division/National Library of Medicine. 3619 citations January, 1990-June, 1998. Available from: http://www.nlm.nih.gov/archive/20040831/pubs/cbm/zinc.html as of November 2, 1998.
A - Alimentary tract and metabolism
QA - Alimentary tract and metabolism
Recommended intakes may be increased and/or supplementation may be necessary in the following conditions (based on documented zinc deficiency): alcoholism; burns; cirrhosis of the liver; diabetes mellitus; eating disorders - anorexia nervosa, bulimia; gastrectomy; genetic disorders - celiac, Crohn's, diarrhea, sprue, ulcerative colitis; intestinal parasitism; malabsorption syndromes associated with pancreatic insufficiency - pancreatic disease, cystic fibrosis; renal diseases - nephrotic syndrome, renal failure, uremia; short bowel syndrome; skin disorders - exfoliative dermatoses, psoriasis; prolonged stress; prolonged trauma. /Zinc supplements/
Zinc is an important mineral found in almost every cell in the human body. It promotes the activity of about 100 enzymes. Zinc deficiency is often associated with an increased risk of infection. When they are used to treat the common cold, zinc supplements may interfere with rhinovirus cleavage or adhesion and may play a role in protecting plasma membranes from microbial toxins and complement.
Please refer to DrugBank entry [DB01593]
Zinc can enter the body through the lungs, skin, and gastrointestinal tract. Intestinal absorption of zinc is controlled by zinc carrier protein CRIP. Zinc also binds to metallothioneins, which help prevent absorption of excess zinc. Zinc is widely distributed and found in all tissues and tissues fluids, concentrating in the liver, gastrointestinal tract, kidney, skin, lung, brain, heart, and pancreas. In the bloodstream zinc is found bound to carbonic anhydrase in erythrocytes, as well as bound to albumin, _2-macroglobulin, and amino acids in the the plasma. Albumin and amino acid bound zinc can diffuse across tissue membranes. Zinc is excreted in the urine and faeces. (L49)
White or almost white, hygroscopic, crystalline powder.
USEPA; Ambient Water Quality Criteria Doc: Zinc (1980) EPA 400/5-80-079
USEPA; Ambient Water Quality Criteria Doc: Zinc (1987) EPA 400/5-87-003
Arvidson, B. A Review of Axonal Transport of Metals. Toxicology 88: 1-14 (19994) Recent findings regarding axonal transport of metals, including zinc.
For more Special Reports (Complete) data for ZINC GLUCONATE (6 total), please visit the HSDB record page.
Toxic pollutant designated pursuant to section 307(a)(1) of the Clean Water Act and is subject to effluent limitations. /Zinc and compounds/
For total recoverable zinc the criterion-to protect freshwater aquatic life ... is 47 ng/l as a 24 hr average ... at hardnesses of 50, 100, and 200 mg/l as CaCO3 the concentration of total recoverable zinc should not exceed 180, 320, 570 ug/l at any time. /Soluble zinc salts/
For total recoverable zinc the criterion to protect saltwater aquatic life ... is 58 ug/l as a 24 hr average and the concentration should not exceed 170 ug/l at any time. /Soluble zinc salts/
(AZ) ARIZONA 5000 ug/l /Zinc/
(MN) MINNESOTA 2000 ug/l /Zinc/
EPA 5000 ug/l /Zinc/
EPA 2000 ug/l /Zinc, Lifetime health advisory/
SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.
Large doses of zinc may inhibit copper absorption in the intestine; zinc supplements should be taken at least 2 hours after the administration of copper supplements. /Zinc supplements/
Thiazide diuretics have been found to increase urinary zinc excretion. /Zinc supplements/
Concurrent use of large amounts of fiber, phosphorus, or phytates with zinc supplements may reduce zinc absorption by formation of nonabsorbable complexes; food containing fiber, phosphorus, or phytates should be taken at least 2 hours after zinc supplements. /Zinc supplements/
Some studies have found that folate can decrease the absorption of zinc, but not in the presence of excessive zinc; other studies have found no inhibition. /Zinc supplements/
For more Interactions (Complete) data for ZINC GLUCONATE (8 total), please visit the HSDB record page.
The CIR Expert Panel concluded that the following 27 zinc salts are safe in cosmetics in the present practices of use and concentration described in this safety assessment when formulated to be non-irritating...Zinc Gluconate...
Safe for use in cosmetics, with qualifications
Anaemia results from the excessive absorption of zinc suppressing copper and iron absorption, most likely through competitive binding of intestinal mucosal cells. Unbalanced levels of copper and zinc binding to Cu,Zn-superoxide dismutase has been linked to amyotrophic lateral sclerosis (ALS). Stomach acid dissolves metallic zinc to give corrosive zinc chloride, which can cause damage to the stomach lining. Metal fume fever is thought to be an immune response to inhaled zinc. (L48, L49, A49)
Ingestion of large doses of zinc causes stomach cramps, nausea, and vomiting. Acute inhalation of large amounts of zinc causes metal fume fever, which is characterized by chills, fever, headache, weakness, dryness of the nose and throat, chest pain, and coughing. Dermal contact with zinc results in skin irritation. (L49)
Toxic pollutant designated pursuant to section 307(a)(1) of the Clean Water Act and is subject to effluent limitations. /Zinc and compounds/
For total recoverable zinc the criterion-to protect freshwater aquatic life ... is 47 ng/l as a 24 hr average ... at hardnesses of 50, 100, and 200 mg/l as CaCO3 the concentration of total recoverable zinc should not exceed 180, 320, 570 ug/l at any time. /Soluble zinc salts/
For total recoverable zinc the criterion to protect saltwater aquatic life ... is 58 ug/l as a 24 hr average and the concentration should not exceed 170 ug/l at any time. /Soluble zinc salts/
(AZ) ARIZONA 5000 ug/l /Zinc/
(MN) MINNESOTA 2000 ug/l /Zinc/
EPA 5000 ug/l /Zinc/
EPA 2000 ug/l /Zinc, Lifetime health advisory/
ZINC GLUCONATE
Copper Absorption Inhibitor [EPC]; Decreased Copper Ion Absorption [PE]
ZINCUM GLUCONICUM
Copper Absorption Inhibitor [EPC]; Decreased Copper Ion Absorption [PE]
Please refer to DrugBank entry [DB01593]
Feces and urine
Stored primarily in skeletal muscle and bone.
Please refer to DrugBank entry [DB01593]
CIR ingredient: Zinc Gluconate
Used as dietary supplement and food additive; Also used in human and veterinary medicine; [HSDB] Used as a chelating agent, high alkalinity bottle cleanser, finish remover, and in the tanning and textile industries; [Merck Index]
Textiles (Fiber & Fabric Manufacturing) [Category: Industry]
Dietary supplement and food additive
MEDICATION
MEDICATION (VET)
Descote zinc gluconate: Microencapsulated beaded powder containing 25% zinc gluconate & 75% edible coating
USP powder, granular & direct compressible grades
USP21 powder & fine granular grades
용도zinc gluconate helps maintain the skin in good condition and acts as a deodorant by preventing the growth of micro-organisms, such as bacteria, fungi or yeast, in a formulation. Zinc gluconate could also be effectively used in anti-acne products.
순도시험(1) 카드뮴 : 이 품목 5.0g을 취하여 원자흡광광도법 또는 유도결합플라즈마발광광도법에 따라 시험할 때, 그 양은 2.0ppm 이하이어야 한다. (2) 염화물 : 이 품목 0.3g을 취하여 염화물시험법에 따라 시험할 때, 그 양은 0.01N 염산 0.42mL에 대응하는 양 이하이어야 한다. (3) 황산염 : 이 품목 0.49g을 취하여 황산염시험법에 따라 시험할 때, 그 양은 0.01N 황산 0.5mL에 대응하는 양 이하이어야 한다. (4) 납 : 이 품목 5.0g을 취하여 원자흡광광도법 또는 유도결합플라즈마발광광도법에 따라 시험할 때, 그 양은 2.0ppm 이하이어야 한다. (5) 비소 : 이 품목을 비소시험법에 따라 시험할 때, 그 양은 4.0ppm 이하이어야 한다. (6) 환원물질 : 이 품목 약 1g을 정밀히 달아 250mL 삼각플라스크에 넣고 물 10mL를 가하여 이 액에 알칼리구연산동시액 25mL를 가하고 작은 비이커로 마개를 한 후 정확히 5분간 조용히 가열하고 실온으로 급냉한다. 이 액에 초산(1→10) 25mL, 0.1N 요오드용액 10mL, 묽은염산 10mL 및 전분시액 3mL를 가하여 청색이 없어질 때까지 0.1N 치오황산나트륨용액으로 적정할 때, 그 양은 1.0% 이하이어야 한다.V1 : 0.1N 요오드용액의 첨가량(mL)N1 : 0.1N 요오드용액의 규정농도V2 : 0.1N 치오황산나트륨용액의 소비량(mL)N2 : 0.1N 치오황산나트륨용액의 규정농도2.7 : D-글루코오스에 대한 실험적 대응량
확인시험(1) 이 품목의 수용액(1→10)은 확인시험법 중 아연염의 반응을 나타낸다. (2) 「글루콘산나트륨」의 확인시험 (2)에 따라 시험한다.
정량법이 품목 약 0.7g을 정밀히 달아 물 100mL를 가하고 필요하면 가온하여 녹인 후 암모니아‧염화암모늄액 5mL를 가한 후 에리오크롬블랙시액 0.1mL를 가한다. 이 용액이 청색으로 변할 때까지 0.05M 이.디.티.에이.이나트륨용액으로 적정한다.0.05M 이.디.티.에이.이나트륨용액 1mL = 22.78mg C12H22O14Zn